# Lilly’s Weight-Loss Drug Situation Improving, FDA Reports ## Key Points: – The FDA has confirmed that the weight-loss drug, lorcaserin, from Eli Lilly and Co. is no longer reported in shortage. – This medication was previously facing shortages in the United States due to voluntary recalls by different manufacturers. – The drug lorcaserin is approved to be used with a reduced-calorie diet and increased physical activity to help with weight management. – Patients are advised to consult with healthcare providers before starting or stopping any medications, including weight-loss drugs. Eli Lilly and Co.’s weight-loss drug, lorcaserin, has been a topic of concern due to shortages in the market caused by recalls. However, there is good news as the FDA has announced that the drug is no longer reported in shortage. This development should provide relief to patients relying on lorcaserin for weight management. If you are considering weight-loss medication, always seek guidance from healthcare professionals to ensure safe and effective usage. To explore weight-loss options and receive personalized guidance, consider reaching out to Mindful Evolution. Our telehealth services are available in Alabama, Arkansas, Florida, Georgia, Louisiana, Mississippi, North Carolina, New York, South Carolina, Tennessee, Texas, and Virginia. Contact us at 954-639-9960 or visit our website for more information and support.*disclaimer: Weight loss varies by individual and telehealth services available in AL, AR, FL, GA, LA, MS, NC, NY, SC, TN, TX, VA.*